医学
怀孕
胎儿生长
阿司匹林
并发症
胎儿
产科
低分子肝素
宫内生长受限
重症监护医学
肝素
内科学
遗传学
生物
作者
Nathan R. Blue,Jessica Pagé,Robert M. Silver
标识
DOI:10.1016/j.ogc.2021.03.002
摘要
Fetal growth restriction (FGR) is a common obstetric complication that predisposes to mortality across the lifespan. Women with a prior pregnancy affected by FGR have a 20% to 30% risk of recurrence, but effective preventive strategies are lacking. Pharmacologic interventions to prevent FGR are lacking. Low-dose aspirin may be somewhat effective, but low-molecular-weight heparin and sildenafil are not. Surveillance in a subsequent pregnancy may consist of serial ultrasonography with timing and frequency determined by the clinical severity in the index pregnancy. Once FGR is diagnosed, the principal management strategy consists of close surveillance and carefully timed delivery.
科研通智能强力驱动
Strongly Powered by AbleSci AI